PixCell Medical has received Health Canada Class III licensing for its HemoScreen point-of-care hematology analyzer and signed a Canadian distribution agreement with Inter Medico, expanding access to decentralized CBC testing.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.